<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://ltrc.sciwiki.in/index.php?action=history&amp;feed=atom&amp;title=CUMYL-PEGACLONE</id>
	<title>CUMYL-PEGACLONE - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://ltrc.sciwiki.in/index.php?action=history&amp;feed=atom&amp;title=CUMYL-PEGACLONE"/>
	<link rel="alternate" type="text/html" href="https://ltrc.sciwiki.in/index.php?title=CUMYL-PEGACLONE&amp;action=history"/>
	<updated>2026-10-17T20:33:29Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://ltrc.sciwiki.in/index.php?title=CUMYL-PEGACLONE&amp;diff=6516&amp;oldid=prev</id>
		<title>Digantasen: ইংরেজি উইকিপিডিয়ার “CUMYL-PEGACLONE” নিবন্ধের বাংলা অনুবাদ</title>
		<link rel="alternate" type="text/html" href="https://ltrc.sciwiki.in/index.php?title=CUMYL-PEGACLONE&amp;diff=6516&amp;oldid=prev"/>
		<updated>2026-10-15T08:45:18Z</updated>

		<summary type="html">&lt;p&gt;ইংরেজি উইকিপিডিয়ার “CUMYL-PEGACLONE” নিবন্ধের বাংলা অনুবাদ&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:CUMYL-PEGACLONE.svg|thumb]]&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
! colspan=&amp;quot;2&amp;quot; | Drug&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;iupac_name&amp;#039;&amp;#039;&amp;#039; || 2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-pentyl-1H-pyrido[4,3-b]indol-1-one&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;width&amp;#039;&amp;#039;&amp;#039; || 200px&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_au&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_br&amp;#039;&amp;#039;&amp;#039; || F2&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_br_comment&amp;#039;&amp;#039;&amp;#039; || &amp;lt;ref&amp;gt;Anvisa. (2023-07-24). [https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial]. [[wikipedia:Diário Oficial da União|Diário Oficial da União]].&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_ca&amp;#039;&amp;#039;&amp;#039; || Schedule II&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_de&amp;#039;&amp;#039;&amp;#039; || Anlage II&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_uk&amp;#039;&amp;#039;&amp;#039; || PSA&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_un&amp;#039;&amp;#039;&amp;#039; || P II&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_un_comment&amp;#039;&amp;#039;&amp;#039; || &amp;lt;ref&amp;gt;[https://www.unodc.org/LSS/Substance/Details/d8783925-3233-41a9-b9aa-ddeb60242828 Substance Details CUMYL-PEGACLONE].&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;routes_of_administration&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;excretion&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;cas_number&amp;#039;&amp;#039;&amp;#039; || 2160555-55-3&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;pubchem&amp;#039;&amp;#039;&amp;#039; || 134818034&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;kegg&amp;#039;&amp;#039;&amp;#039; || C22782&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chemspiderid&amp;#039;&amp;#039;&amp;#039; || 68003813&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;unii&amp;#039;&amp;#039;&amp;#039; || CUT2RV7EIQ&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;smiles&amp;#039;&amp;#039;&amp;#039; || CC(C1=CC=CC=C1)(C)N2C=CC(N(CCCCC)C3=C4C=CC=C3)=C4C2=O&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;c&amp;#039;&amp;#039;&amp;#039; || 25&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;h&amp;#039;&amp;#039;&amp;#039; || 28&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;n&amp;#039;&amp;#039;&amp;#039; || 2&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;o&amp;#039;&amp;#039;&amp;#039; || 1&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchi&amp;#039;&amp;#039;&amp;#039; || 1S/C25H28N2O/c1-4-5-11-17-26-21-15-10-9-14-20(21)23-22(26)16-18-27(24(23)28)&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchikey&amp;#039;&amp;#039;&amp;#039; || AWHWTKXMUJLSRM-UHFFFAOYSA-N&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;CUMYL-PEGACLONE&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;SGT-151&amp;#039;&amp;#039;&amp;#039;) হলো একটি [[wikipedia:Gamma-carboline|gamma-carboline]] ভিত্তিক [[wikipedia:Synthetic cannabinoid|synthetic cannabinoid]] (কৃত্রিম ক্যানাবিনয়েড), যা [[wikipedia:Designer drug|designer drug]] হিসেবে বিক্রি হয়ে থাকে।&amp;lt;ref&amp;gt;(August 2017). &amp;quot;Identification and quantification of synthetic cannabinoids in &amp;#039;spice-like&amp;#039; herbal mixtures: Update of the German situation in early 2017&amp;quot;. &amp;#039;&amp;#039;Forensic Science International&amp;#039;&amp;#039;. 277 51–58. doi:[https://doi.org/10.1016/j.forsciint.2017.05.019 10.1016/j.forsciint.2017.05.019].&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;(July 2017). &amp;quot;Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE&amp;quot;. &amp;#039;&amp;#039;Drug Testing and Analysis&amp;#039;&amp;#039;. 10 (3) 597–603. doi:[https://doi.org/10.1002/dta.2237 10.1002/dta.2237].&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;(January 2018). &amp;quot;Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples&amp;quot;. &amp;#039;&amp;#039;Drug Testing and Analysis&amp;#039;&amp;#039;. 10 (5) 886–891. doi:[https://doi.org/10.1002/dta.2352 10.1002/dta.2352].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid30468574&amp;quot;&amp;gt;(February 2019). &amp;quot;Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market?&amp;quot;. &amp;#039;&amp;#039;Drug Testing and Analysis&amp;#039;&amp;#039;. 11 (2) 347–349. doi:[https://doi.org/10.1002/dta.2545 10.1002/dta.2545].&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;(September 2020). [https://biblio.ugent.be/publication/8687072 In vitro activity profiling of Cumyl-PEGACLONE variants at the CB&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; receptor: Fluorination versus isomer exploration]. &amp;#039;&amp;#039;Drug Testing and Analysis&amp;#039;&amp;#039;. 12 (9) 1336–1343. doi:[https://doi.org/10.1002/dta.2870 10.1002/dta.2870].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid33185835&amp;quot;&amp;gt;(November 2020). &amp;quot;Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia&amp;quot;. &amp;#039;&amp;#039;Forensic Science, Medicine, and Pathology&amp;#039;&amp;#039;. 17 (1) 3–9. doi:[https://doi.org/10.1007/s12024-020-00334-0 10.1007/s12024-020-00334-0].&amp;lt;/ref&amp;gt; CUMYL-PEGACLONE-এ বিদ্যমান গামা-কার্বোলিন মূল কাঠামোটি এর আগে কোনো ডিজাইনার ক্যানাবিনয়েডে দেখা যায়নি, যদিও এটি ২০০১ সালে [[wikipedia:Bristol-Myers Squibb|Bristol-Myers Squibb]] কর্তৃক প্রকাশিত অন্যান্য গামা-কার্বোলিন ক্যানাবিনয়েডের কাঠামোর সাথে সাদৃশ্যপূর্ণ।&amp;lt;ref&amp;gt;WO&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;(May 2003). &amp;quot;Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties&amp;quot;. &amp;#039;&amp;#039;Journal of Medicinal Chemistry&amp;#039;&amp;#039;. 46 (11) 2110–6. doi:[https://doi.org/10.1021/jm020329q 10.1021/jm020329q].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid31854124&amp;quot;&amp;gt;(March 2020). &amp;quot;Adding more &amp;quot;spice&amp;quot; to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists&amp;quot;. &amp;#039;&amp;#039;Drug Testing and Analysis&amp;#039;&amp;#039;. 12 (3) 297–315. doi:[https://doi.org/10.1002/dta.2752 10.1002/dta.2752].&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== আইনি অবস্থা ==&lt;br /&gt;
সুইডেনের জনস্বাস্থ্য সংস্থা ২০১৯ সালের ১৮ জানুয়ারি CUMYL-PEGACLONE-কে একটি মাদকদ্রব্য হিসেবে শ্রেণীবদ্ধ করে।&amp;lt;ref&amp;gt;(18 January 2019). [https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2019/januari/sexton-nya-amnen-klassas-som-narkotika-eller-halsofarlig-vara/ Sexton nya ämnen klassas som narkotika eller hälsofarlig vara]. Folkhälsomyndigheten.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
যুক্তরাষ্ট্রে, DEA (ড্রাগ এনফোর্সমেন্ট অ্যাডমিনিস্ট্রেশন) ২০২৩ সালের ১২ ডিসেম্বর থেকে সাময়িকভাবে CUMYL-PEGACLONE-কে &amp;#039;শিডিউল ১&amp;#039; (Schedule I) মর্যাদায় অন্তর্ভুক্ত করেছে, যা সর্বোচ্চ ২ বছর পর্যন্ত কার্যকর থাকবে।&amp;lt;ref&amp;gt;(12 December 2023). [https://www.federalregister.gov/documents/2023/12/12/2023-27243/schedules-of-controlled-substances-temporary-placement-of-mdmb-4en-pinaca-4f-mdmb-butica Federal Register :: Request Access].&amp;lt;/ref&amp;gt; ২০২৫ সালের ১১ ডিসেম্বর, DEA CUMYL-PEGACLONE-কে স্থায়ীভাবে &amp;#039;শিডিউল ১&amp;#039;-এ অন্তর্ভুক্ত করার জন্য আবেদন করে। এই প্রস্তাবের ওপর ৩০ দিনের একটি গণ-পরামর্শের সময়সীমা ২০২৬ সালের ১২ জানুয়ারি শেষ হবে।&amp;lt;ref&amp;gt;(11 December 2025). [https://www.federalregister.gov/documents/2025/12/11/2025-22495/schedules-of-controlled-substances-placement-of-cumyl-pegaclone-in-schedule-i Federal Register :: Request Access].&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== আরও দেখুন ==&lt;br /&gt;
* [[5F-CUMYL-PEGACLONE|5F-CUMYL-PEGACLONE]]&lt;br /&gt;
* [[wikipedia:CUMYL-CB-MEGACLONE|CUMYL-CB-MEGACLONE]]&lt;br /&gt;
* [[wikipedia:CUMYL-CH-MEGACLONE|CUMYL-CH-MEGACLONE]]&lt;br /&gt;
* [[wikipedia:CUMYL-BC-HPMEGACLONE-221|CUMYL-BC-HPMEGACLONE-221]]&lt;br /&gt;
* [[CUMYL-PINACA|CUMYL-PINACA]]&lt;br /&gt;
* [[wikipedia:CUMYL-5F-P7AICA|CUMYL-5F-P7AICA]]&lt;br /&gt;
* [[wikipedia:UR-12|UR-12]]&lt;br /&gt;
&lt;br /&gt;
== তথ্যসূত্র ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&amp;#039;&amp;#039;উৎস:&amp;#039;&amp;#039; ইংরেজি উইকিপিডিয়ার “CUMYL-PEGACLONE” নিবন্ধের অনুবাদ।&lt;br /&gt;
&amp;#039;&amp;#039;মূল নিবন্ধ:&amp;#039;&amp;#039; https://en.wikipedia.org/wiki/CUMYL-PEGACLONE&lt;br /&gt;
&amp;#039;&amp;#039;এই অনুবাদটি স্বয়ংক্রিয়ভাবে প্রস্তুত করা হয়েছে।&amp;#039;&amp;#039;&lt;/div&gt;</summary>
		<author><name>Digantasen</name></author>
	</entry>
</feed>